Caribou Biosciences CRBU
NASDAQ CRBU
$1.24 +0.01 (+0.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Share-based Compensation (2020 - 2026)

Updated

Caribou Biosciences' Share-based Compensation came in at $2.48 million for Q2 2026, down 20.8% from $3.13 million a year earlier but up 5.1% from the prior quarter.

Analysis

Caribou Biosciences (CRBU) Share-based Compensation (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Caribou Biosciences reported Share-based Compensation of $10.5 million, down 29.9% year-over-year; for FY2025, it was $12.68 million, down 24.1% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 66.1% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $16.71 million in FY2024 (+21.5%), $13.75 million in FY2023 (+17.4%), $11.72 million in FY2022 (+239.7%) and $3.45 million in FY2021 (+244.2%).
  • The five-year range for quarterly Share-based Compensation is $935,000 (Q3 2021) to $4.74 million (Q2 2024).
  • Year-over-year, Share-based Compensation has declined for six consecutive quarters, with an average decline of 16.0% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q1 2022 (growth of 781.6%), and the weakest in Q1 2026 (a decline of 39.3%).
  • Business Quant data shows CRBU's Share-based Compensation at $2.36 million (Q1 2026), $2.74 million (Q4 2025) and $2.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Caribou Biosciences 130.37 Mn -386.16 Mn - 2.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.48 Mn
Mar 31, 2026 2.36 Mn
Dec 31, 2025 2.74 Mn
Sep 30, 2025 2.93 Mn
Jun 30, 2025 3.13 Mn
Mar 31, 2025 3.88 Mn
Dec 31, 2024 3.91 Mn
Sep 30, 2024 4.07 Mn
Jun 30, 2024 4.74 Mn
Mar 31, 2024 3.99 Mn
Dec 31, 2023 3.56 Mn
Sep 30, 2023 3.48 Mn
Jun 30, 2023 3.59 Mn
Mar 31, 2023 3.13 Mn
Dec 31, 2022 3.10 Mn
Sep 30, 2022 2.67 Mn
Jun 30, 2022 2.92 Mn
Mar 31, 2022 3.02 Mn
Dec 31, 2021 1.58 Mn
Sep 30, 2021 935,000.00
API Access

Caribou Biosciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRBU&period=max&api_key=YOUR_API_KEY